(19)
(11) EP 2 211 618 A1

(12)

(43) Date of publication:
04.08.2010 Bulletin 2010/31

(21) Application number: 08838205.6

(22) Date of filing: 10.10.2008
(51) International Patent Classification (IPC): 
A01N 43/40(2006.01)
A61K 31/445(2006.01)
A61K 31/405(2006.01)
(86) International application number:
PCT/US2008/079447
(87) International publication number:
WO 2009/049113 (16.04.2009 Gazette 2009/16)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 11.10.2007 US 979161 P

(71) Applicant: Glaxo Group Limited
Greenford, Middlesex UB6 0NN (GB)

(72) Inventors:
  • SEHON, Clark, A.
    King Of Prussia PA 19406 (US)
  • WANG, Gren, Z.
    King Of Prussia PA 19406 (US)
  • VIET, Andrew, Q.
    Schwenksville PA 19473 (US)
  • ZHANG, Jing
    Collegeville Pennsylvania 19426 (US)

(74) Representative: Florence, Julia Anne et al
GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) PIPERIDINYLHYDROXYETHYLPIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTORS